Risk Stratification of MACE in Heart Failure Patients Who Undergoing CABG

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorTomsk National Research Medical Center of the Russian Academy of Sciences

About this trial

PROFILE-HF is a multicenter, observational, prospective study of the clinical course and outcomes of chronic heart failure (HF) and coronary artery disease (CAD) in patients undergoing coronary artery bypass grafting (CABG).

The objective of the study is to develop a method for assessing the risk of adverse cardiovascular events in patients with CAD and HF who have undergone CABG, based on preoperative GDF-15 concentrations.

The study will have a 12-month follow-up period; one in-person visit is planned at the end of the follow-up period. If it is not possible to visit a doctor in person, information will be collected through telephone contact with the patient or his relative or person caring for the patient.

Eligibility criteria

Qualifiers

Heart Failure

Planned coronary artery bypass grafting

Disqualifiers

Myocardial infarction

Stroke

Presence of implanted devices;

Need for additional cardiac surgery other than coronary artery bypass grafting (valve repair, aneurysm);

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

No trial groups listed